Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 3/20 | 0.48 |
| ▸ | ADH1C | P00326 | 3/20 | 0.48 |
| ▸ | ADH1A | P07327 | 3/20 | 0.48 |
| ▸ | ADH7 | P40394 | 3/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.48 |
| ▸ | ADH4 | P08319 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 8/20 | 0.39 |
| ▸ | CA2 | P00918 | 8/20 | 0.39 |
| ▸ | CA9 | Q16790 | 7/20 | 0.39 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.39 |
| ▸ | CA12 | O43570 | 3/20 | 0.39 |
| ▸ | CA7 | P43166 | 3/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.39 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.39 |
| ▸ | CA3 | P07451 | 2/20 | 0.39 |
| ▸ | CA4 | P22748 | 2/20 | 0.39 |
| ▸ | CA6 | P23280 | 2/20 | 0.39 |
| ▸ | CA5A | P35218 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3848292 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH7EPHX1 | |
| SCHEMBL28083740 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH7EPHX1 | |
| SCHEMBL27710639 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH7EPHX1 | |
| SCHEMBL28346019 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH7EPHX1 | |
| SCHEMBL55808 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH7EPHX1 | |
| SCHEMBL28114353 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH7EPHX1 | |
| SCHEMBL8770337 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH7EPHX1 | |
| SCHEMBL29020561 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH7EPHX1 | |
| SCHEMBL21144229 | 1.00 | ADH1B (0.48) | ADH1BADH1CADH1AADH7EPHX1 | |
| SCHEMBL28595704 | 0.98 | ADH1B (0.46) | ADH1BADH1CADH1AADH7EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105726351-B | Synergistic compositions, formulations and related methods for reducing ultraviolet-induced lipid peroxidation | 伊诺莱克斯投资公司 | 2022-07-05 | — | — | CN | claimed |
| CN-105726351-A | Synergistic compositions, formulations and related methods for reducing ultraviolet-induced lipid peroxidation | 伊诺莱克斯投资公司 | 2016-07-06 | — | — | CN | claimed |
| CN-1480132-A | Protective solution for preventing local ischemic damage | �����ġ����ղ�ʿ��ѧ����˾ | 2004-03-10 | — | — | CN | claimed |
| CN-1310629-A | Combined administration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions | WARNER LAMBERT CO (US) | 2001-08-29 | — | — | CN | claimed |
| CN-117101871-A | Flotation method of rhodochrosite | 中南大学 | 2023-11-24 | — | — | CN | disclosed |
| EP-4159212-A1 | P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FOR THE TREATMENT OF FSHD | Fulcrum Therapeutics, Inc. (US) | 2023-04-05 | — | — | EP | disclosed |
| CN-115802891-A | Bio-based alkyl glyceryl ethers and methods of making and using the same | 伊诺莱克斯投资公司 | 2023-03-14 | — | — | CN | disclosed |
| CN-111787800-B | Antimicrobial compositions comprising a hydroxamic acid and methods of inhibiting microbial growth therewith | 金伯利-克拉克环球有限公司 | 2022-11-25 | — | — | CN | disclosed |
| CN-112592305-B | Organic compound and preparation method and application thereof | 中南大学 | 2022-10-18 | — | — | CN | disclosed |
| CN-114748622-A | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD | 弗尔康医疗公司 | 2022-07-15 | — | — | CN | disclosed |
| CN-114732910-A | P38 kinase inhibitor reduces DUX4 and downstream gene expression for treatment of FSHD | 弗尔康医疗公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-105726351-B | Synergistic compositions, formulations and related methods for reducing ultraviolet-induced lipid peroxidation | 伊诺莱克斯投资公司 | 2022-07-05 | — | — | CN | disclosed |
| WO-1997038987-A1 | HERBICIDAL BENZOYLISOTHIAZOLES | BASF AKTIENGESELLSCHAFT (DE) | 1997-10-23 | — | — | WO | disclosed |
| WO-1997038996-A1 | HERBICIDAL HETEROCYCLICALLY SUBSTITUTED BENZOYLISOTHIAZOLES | BASF AKTIENGESELLSCHAFT (DE) | 1997-10-23 | — | — | WO | disclosed |
| WO-1997038988-A1 | HERBICIDAL HETEROCYCLICALLY ANNULATED BENZOYLISOTHIAZOLES | BASF AKTIENGESELLSCHAFT (DE) | 1997-10-23 | — | — | WO | disclosed |
| CN-1091288-A | The oxytocin antagonist | OTSUKA PHARMA CO LTD (JP) | 1994-08-31 | — | — | CN | disclosed |
| CN-1023801-C | 2-Oxa-isocephem compounds, compositions containing same and processes for preparing same | OTSUKA PHARMA CO LTD (JP) | 1994-02-16 | — | — | CN | disclosed |
| CN-1036758-A | Bicyclic amine compound and preparation method thereof | FUJISAWA PHARMACEUTICAL CO (JP) | 1989-11-01 | — | — | CN | disclosed |
| CN-1031376-A | Pyrazolopyridine compound and preparation method thereof | FUJISAWA PHARMACEUTICAL CO (JP) | 1989-03-01 | — | — | CN | disclosed |
| CN-88102161-A | 2-oxa-isocephem compounds, compositions containing them and processes for their preparation | — | 1988-10-05 | — | — | CN | disclosed |